Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$51.22 - $60.16 $343,174 - $403,072
-6,700 Reduced 3.35%
193,300 $10.2 Million
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $28.9 Million - $45.3 Million
-603,500 Reduced 75.11%
200,000 $10.8 Million
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $56.4 Million - $95.6 Million
-885,100 Reduced 52.42%
803,500 $56.3 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $42.8 Million - $133 Million
1,594,000 Added 1684.99%
1,688,600 $141 Million
Q3 2023

Nov 14, 2023

BUY
$29.46 - $36.61 $2.79 Million - $3.46 Million
94,600 New
94,600 $2.79 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $1.16 Million - $1.64 Million
30,000 Added 100.0%
60,000 $2.91 Million
Q3 2021

Nov 12, 2021

SELL
$18.54 - $35.74 $6.3 Million - $12.2 Million
-340,000 Reduced 91.89%
30,000 $1.07 Million
Q3 2020

Nov 16, 2020

BUY
$20.58 - $28.96 $7.61 Million - $10.7 Million
370,000 New
370,000 $8.01 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.39B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.